Using extracellular vesicles, researchers demonstrate how nuclear magnetic resonance can optimize clinical-grade manufacturing, supporting scalable regenerative medicine and future cell-free therapeutic...
Read More »
NurExone Biologic Inc. and BioXtek Inc. are advancing extracellular vesicles manufacturing, focusing on scalable GMP production of MSC-derived exosomes for regenerative therapies...
Read More »
LEON secures oversubscribed financing to commercialize scalable nanoparticle systems supporting RNA medicines, cancer vaccines...
Read More »
The 7th Exosome-Based Therapeutics Development Summit in Boston will unite global experts to advance extracellular vesicles with improved characterization, targeted delivery, and GMP...
Read More »
Ciloa is advancing a novel therapy by combining adiponectin with extracellular vesicles to treat type 2 diabetes and obesity, backed by €6.5 million in funding for clinical development and GMP manufacturing...
Read More »
Future Health GCC’s new GMP-compliant exosome production facility in Dubai enables scalable, quality-controlled extracellular vesicles manufacturing...
Read More »
A new collaboration between RoosterBio and Thermo Fisher Scientific accelerates development of cell-based therapies and extracellular vesicles by combining hMSC technology with scalable GMP...
Read More »
Coya Therapeutics advances a platform using regulatory T cell-derived extracellular vesicles to suppress inflammation in neurodegenerative diseases, with clinical-scale manufacturing set to begin in...
Read More »
Lonza and Exogenus Therapeutics partner to develop a GMP-compliant manufacturing process for Exo-101, an extracellular vesicles-based therapy with regenerative and anti-inflammatory properties...
Read More »
Exosome RNA Exosome RNA Research & Industry News
